Galectin - Method for Enhancing Specific Immunotherapies in Cancer Treatment

Document Type

Patent

Publication Date

1-22-2018

Abstract

Methods and compositions of the invention relate to the enhancement of specific immunotherapies in cancer treatment. In particular, aspects of the invention relate to novel approaches to boost immune function using a complex carbohydrate pharmaceutical compound alone or in combination with other targeted immunotherapy to increase the efficacy of immunotherapy of cancer.

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

Specialty/Research Institute

Earle A. Chiles Research Institute

Location

United States

Comments

Patent Number: 10,398,778

Assignee

Galectin Therapeutics, Inc. (Norcross, GA); Providence Health & Services--Oregon (Portland, OR)

Family ID

50278770

Serial Number

15/876,367

Tech ID

12-05-INV

Link to Full Text

Share

COinS